Virginia Commonwealth University Clinical Research Unit — Richmond, Virginia

Virginia Commonwealth University Clinical Research Unit is a clinical research site located in Richmond, Virginia, United States 23298.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Virginia Commonwealth University Clinical Research Unit has participated in 2 clinical trials.

Therapeutic areas: Amyotrophic Lateral Sclerosis, Sickle Cell Disease.

Sponsors: Seelos Therapeutics, Inc., Cyclerion Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Richmond

Browse all research sites in Virginia · View every site in Richmond

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Virginia Commonwealth University Clinical Research Unit?

Virginia Commonwealth University Clinical Research Unit has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Virginia Commonwealth University Clinical Research Unit conducted?

Virginia Commonwealth University Clinical Research Unit has 2 clinical trials on record. Their work covers Amyotrophic Lateral Sclerosis, Sickle Cell Disease.

Is Virginia Commonwealth University Clinical Research Unit accredited by Crixeo Clinical Trials?

Virginia Commonwealth University Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Virginia Commonwealth University Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.